+2 MM articles scientifics and academics

ARTICLES

Filter

Active filters 0	Remove

Refine your searches by:

Collections

Sports

Medicine / Sub specialtie

Languages

Countries

USA

Poland

Years

2020

2018

Filter

2 Articles

1 of 1 pages | 10 records | more records»

Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus

Mirella Czapska,Kamila Babkiewicz,Szczepan Pabis,Katarzyna Skórzynska-Dziduszko

Sotagliflozin (SOTA) is a dual inhibitor of SGLT1 and SGLT2 used in adults with type 1 diabetes. The mechanism of action, based on the inhibition of both the SGLT1 and SGLT2 cotransporters, allows simultaneous increase of glucose excre... see more

SGLT1 and SGLT2 inhibitor | sotagliflozin | type 1 diabetes (T1D) | HbA1C | hypoglycemia

Journal of Education; Health and Sport , 2018

Free Access

Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose co-transporter inhibitors with insulin for treatment of type 1 diabetes (updated October 2020)

Umesh Dashora,Dipesh C Patel,Robert Gregory,Peter Winocour,Ketan Dhatariya,Susannah Rowles,Andrew Macklin,Gerry Rayman,Dinesh Nagi

Dapagliflozin (sodium-glucose co-transporter (SGLT-2) inhibitor) and sotagliflozin (SGLT-1/2 inhibitor) are two of the drugs of the SGLT inhibitor class which have been recommended by the National Institute for Health and Care Excellence (NICE) in people ... see more

SGLT inhibitors | type 1 diabetes | ketoacidosis | position statement

British Journal of Diabetes , 2020

Free Access

1 of 1 pages | 10 records | more records»